Clinical Trial Update: A Cohort Study of Conversion From Aranesp® to NESP® for the Treatment of Anemia in Dialysis Patients [NA]

View source ↗

Summary

A completed cohort study evaluating the conversion from Aranesp (darbepoetin alfa) to NESP for treating anemia in patients with end-stage renal disease on dialy…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• End-stage Renal Disease

Drugs mentioned

• ARANESP (DARBEPOETIN ALFA)
• NESP

Snippet

Sponsor: The University of Hong Kong | Conditions: Anemia, End Stage Renal Failure on Dialysis | NA | Status: COMPLETED